Infusional 5-fluorouracil and mitomycin C: An effective regimen in the treatment of advanced gastric cancer

Onkologie

Volumn 28, Issue 3, 2005, Pages 128-132

  Rudi, Jochen ^a   Werle, Stefan ^a   Bergtholdt, Doris ^b   Hofheinz, Ralf Dieter ^b  

^a St Hedwig Klinik GmbH   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

5 fluorouracil, infusional; Folinic acid; Gastric cancer, advanced; Mitomycin C

Indexed keywords

FLUOROURACIL; MITOMYCIN C; ANTINEOPLASTIC AGENT; FOLINIC ACID; MITOMYCIN;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HAND FOOT SYNDROME; HEMOLYTIC UREMIC SYNDROME; HUMAN; LEUKOPENIA; LIVER METASTASIS; LUNG TOXICITY; MALE; NAUSEA; PERITONEUM METASTASIS; STOMACH CANCER; SURVIVAL RATE; THROMBOCYTOPENIA; CLASSIFICATION; CLINICAL TRIAL; GERMANY; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; STOMACH TUMOR; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; FLUOROURACIL; GERMANY; HUMANS; INFUSIONS, INTRAVENOUS; LEUCOVORIN; MIDDLE AGED; MITOMYCIN; SEVERITY OF ILLNESS INDEX; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 17244365541     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083244     Document Type: Article

References (24)

1. Glimelius B, Ekström K, Hoffman K, Graf W, Sjoden PO, Haglund U, Svensson C, Enander LK, Linne T, Sellstrom H, Heuman R: Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 1997;8:163-168.
2. Pyrhönen S, Kuitunen T, Nyandoto P, Kouri M: Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995;71:587-591.
3. Vanhoefer U, Rougier P, Wilke H, Ducreux MP, Lacave AJ, Van Cutsem E, Planker M, Santos JG, Piedbois P, Paillot B, Bodenstein H, Schmoll HJ, Bleiberg H, Nordlinger B, Couvreur ML, Baron B, Wils JA: Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol 2000;18:2648-2657.
4. Vanhoefer U, Wilke H, Weh HJ, Clemens M, Harstrick A, Stahl M, Hossfeld DK, Seeber S: Weekly high-dose 5-fluorouracil and folinic acid as salvage treatment in advanced gastric cancer. Ann Oncol 1994;5:850-851.
5. Wilke H, Korn M, Könne CH, Fink U, Preusser P, Vanhoefer U, Wiegmann T, Stahl M, Harstrick A, Klaasen U, Schmoll HJ, Seeber S: Phase II results of weekly infusional high dose FU (HD-FU) plus folinic acid (FA) and biweekly cisplatin (C) for advanced gastric cancer. Ann Oncol 1996;7:46.
6. Stahl M, Vanhoefer U, Fink U, Korn M, Eigler FW, Siewert JR, Seeber S, Wilke H: Phase II study of weekly high-dose 5-fluorouracil and folinic acid plus biweekly alternating cisplatin and epirubicin (FUFACE) in patients with advanced gastric carcinoma. Onkologie 1996;19:416-418.
7. Raida M, Kath R, Arnrich M, Kähler G, Scheele J, Höffken K: A phase II study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly alternating doxorubicin and cisplatin for advanced gastric carcinoma. J Cancer Res Clin Oncol 1998;124: 335-340.
8. Bokemeyer C, Hartmann JT, Lampe CS, Clemens MR, Quietzsch D, Forkmann L, Kanz L: A phase II trial of paclitaxel and weekly 24 h infusion of 5-fluorouracil/folinic acid in patients with advanced gastric cancer. Anticancer Drugs 1997;8:396-399.
9. Kollmannsberger C, Quietzsch D, Haag C, Lingenfelser T, Schroeder M, Hartmann JT, Baronius W, Hempel V, Clemens M, Kanz L, Bokemeyer C: A phase II study of paclitaxel, weekly 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer. Br J Cancer 2000;83:458-462.
10. Kretzschmar A, Reichardt P, Thuss-Patience PC, Hohenberger P, Benten T, Dörken B, Köhne CH: Weekly 24-hour infusion of high-dose 5-fluorouracil plus folinic acid in combination with mitomycin C for the treatment of advanced gastric cancer. Oncology 2000;59:14-17.
11. Hofheinz R, Hartung G, Samel S, Hochhaus A, Pichlmeier U, Post S, Hehlmann R, Queisser W: High-dose 5-fluorouracil/folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. Onkologie 2002;25:155-160.
12. Findlay M, Cunningham D, Norman A, Mansi J, Nicolson M, Hickish T, Nicolson V, Nash A, Sacks N, Ford H, Carter R, Hill A: A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol 1994;5:609-616.
13. Webb A, Cunningham D, Scarffe JH, Harper P, Norman A, Joffe JK, Hughes M, Mansi J, Findlay M, Hill A, Oates J, Nicolson M, Hickish T, O'Brien M, Iveson T, Watson M, Underbill C, Wardley A, Meehan M: Randomized trial comparing epirubicin, cisplatin and fluorouracil versus fluorouracil, doxorubicin and methotrexate in advanced esophagogastric cancer. J Clin Oncol 1997;15:261-267.
14. Schnall S, Macdonald J: Mitomycin therapy in gastric cancer. Oncology 1993;50(suppl 1):70-77.
15. Ross P, Norman A, Cunningham D, Webb A, Iveson T, Padhani A, Prendiville J, Watson M, Massey A, Popescu R, Oates J: A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without Mitomycin C in advanced colorectal cancer. Ann Oncol 1997;8:995-1001.
16. Maisey N, Chau I, Cunningham D, Norman A, Seymour M, Hickish T, Iveson T, O'Brien M, Tebbutt N, Harrington A, Hill M: Multicenter randomized Phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer. J Clin Oncol 2002;20:3130-3136.
17. Hartmann JT, Oechsle K, Quietzsch D, Wein A, Hofheinz RD, Honecker F, Nehls O, Köhne CH, Käfer G, Kanz L, Bokemeyer C: Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: A phase I/II dose escalation study. Br J Cancer 2003;89:2051-2056.
18. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:475-481.
19. Tebbutt NC, Norman A, Cunningham D, Iveson T, Seymour M, Hickish T, Harper P, Maisey N, Mochlinski K, Prior Y, Hill M: A multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus mitomycin C in patients with inoperable oesophago-gastric cancer. Ann Oncol 2002;13:1568-1575.
20. Ross P, Nicolson M, Cunningham D, Valle J, Seymour M, Harper P, Price T, Anderson H, Iveson T, Hickish T, Lofts F, Norman A: Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 2002;20:1996-2004.
21. Cascinu S, Baldelli AM, Catalano V, Giordani P, Beretta GD, Silva RR, Gasparini G, Mari D, Maisano R, Salvagni S, Barni S, Labianca R, Frontini L, Curti C, Catalano G: Infusional 5-fluorouracil, cisplatin and mitomycin C in advanced gastric cancer: A low cost effective regimen. Br J Cancer 2002; 86:213-217.
22. Rusello O, Romanini A, Civalleri D, Rosso R, Nicolin A, Sobrero A: Time-dependent interactions between 5-fluorouracil and mitomycin C on a human colon cancer cell line, HCT-8 in vitro. Eur J Cancer Clin Oncol 1989;25:1598-1603.
23. Hofheinz RD, Hartmann JT, Willer A, Oechsle K, Hartung G, Gnad U, Saussele S, Kreil S, Bokemeyer C, Hehlmann R, Hochhaus A: Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: Results of an extended multicentre phase-I trial. Br J Cancer 2004;91:834-838.
24. Hofheinz RD, Willer A, Weisser A, Gnad U, Saussele S, Kreil S, Hartmann JT, Hehlmann R, Hochhaus A: Pegylated liposomal doxorubicin in combination with mitomycin C, infusional 5-fluorouracil and sodium folinic acid. A phase-I-study in patients with upper gastrointestinal cancer. Br J Cancer 2004;90:1893-1897.